Veterinary Medicines

Paracox 8 oral suspension

Authorised
  • Eimeria acervulina, Live
  • Eimeria maxima, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria maxima, strain MFP, Live
Download as PDF

Product identification

Medicine name:
Paracox 8 oral suspension
Paracox 8
Active substance:
  • Eimeria acervulina, Live
  • Eimeria maxima, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria maxima, strain MFP, Live
Target species:
  • Chicken (chick)
Route of administration:
  • In drinking water use
  • In drinking water/milk use
  • Topical

Product details

Active substance and strength:
  • Eimeria acervulina, Live
    500.00
    unknown
    /
    0.00
    millilitre(s)
  • Eimeria maxima, Live
    200.00
    unknown
    /
    0.00
    millilitre(s)
  • Eimeria maxima, strain MFP, Live
    200.00
    unknown
    /
    0.00
    millilitre(s)
  • Eimeria maxima, strain MFP, Live
    100.00
    unknown
    /
    0.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (chick)
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • In drinking water/milk use
    • Chicken (chick)
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Topical
    • Chicken (chick)
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID2): 1 Box with 1 Vial (Polyethylenterephthalat Glycol-modifiziert) with 20 millilitre(s) (20 millilitre(s))
  • (ID4): 1 Box with 1 Bottle (PolyEthylene TerePhthalate) with 500 millilitre(s) (500 millilitre(s))
  • (ID3): 1 Box with 1 Bottle (PolyEthylene TerePhthalate) with 100 millilitre(s) (100 millilitre(s))
  • (ID1): 1 Box with 1 Vial (Polyethylenterephthalat Glycol-modifiziert) with 4 millilitre(s) (4 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • MSD Animal Health UK Limited
  • Merck Sharp & Dohme Animal Health S.L.
Responsible authority:
  • PEI
Authorisation number:
  • 483a/91
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0210/001
Concerned member states:
  • Austria

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
German (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."